-Expenses increased by 79% to $2,715,450 (2017: $1,519,993) with the single largest contributor being the $709,698 Research and Development costs.
-Net loss from ordinary activities was up 99.4% to $2,646,618 (2017: $1,327,159).
-Expenses by function
Administration (1,603,110)
Just had a proper look and reckon share holders need some further explanation on the above.
Especially look at the accounting for Administration? where did the money go. Its a fare question.
Research and Development- for what?
I will be asking at the AGM.
- Forums
- ASX - By Stock
- KKL
- Ann: Preliminary Final Report
Ann: Preliminary Final Report, page-3
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)